U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07268612) titled 'Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.' on Nov. 24.
Brief Summary: The goal of this observational study is to evaluate the safety and clinical benefit of two doses of CYFENDUS vaccine when used with the concurrent recommended antibacterial regimen for post-exposure prophylaxis to prevent inhalational anthrax and/or anthrax meningitis.
Study Start Date: Nov., 2035
Study Type: OBSERVATIONAL
Condition:
Anthrax
Intervention:
BIOLOGICAL: CYFENDUS
Intramuscular administration of two doses of Anthrax Vaccine Adsorbed, Adjuvanted
Recruitment Status...